The influence of polymorphism of -493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress

Journal of Nutritional Biochemistry

Volumn 19, Issue 9, 2008, Pages 634-641

  Žák, Aleš ^a   Jáchymová, Marie ^a   Tvrzická, Eva ^a   Vecka, Marek ^a   Duffková, Ladislava ^a   Zeman, Miroslav ^a   Slabý, Adolf ^a   Staňková, Barbora ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Atherogenic dyslipidemia; Fatty acid profile; Metabolic syndrome; Microsomal triglyceride transfer protein; Oxidative stress

Indexed keywords

CHOLESTEROL; FATTY ACID; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; BIOCHEMISTRY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; FEMALE; GENDER; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOTE; HOMEOSTASIS; HOMOZYGOTE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MODEL; OXIDATIVE STRESS; PROMOTER REGION; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

BLOOD GLUCOSE; CARRIER PROTEINS; FATTY ACIDS; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; LIPOPROTEINS, LDL; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SEX FACTORS;

EID: 48649094349     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2007.09.001     Document Type: Article

References (56)

1. Grundy S.M. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nat Rev 5 (2006) 295-304
2. Greenberg A.S., and McDaniel M.L. Identifying the links between obesity, insulin resistance and β-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 32 (2002) 24-34
3. Evans J.L., Goldfine I.D., Maddux B.A., and Grodsky G.M. Oxidative stress and stress-activated signalling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23 (2002) 599-622
4. Miranda P.J., DeFronzo R.A., and Califf R.M. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J 149 (2005) 33-45
5. Warensjö E., Sundström J., Lind L., and Vessby B. Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am J Clin Nutr 84 (2006) 442-448
6. Vessby B., Gustafsson I.B., Tengblad S., Boberg M., and Andersson A. Desaturation and elongation of fatty acids and insulin action. Ann N Y Acad Sci 967 (2002) 183-195
7. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol 14 (2003) 15-19
8. Leskinen M.H., Solakivi T., Kunnas T., Alho H., and Nikkari S.T. Serum fatty acids in post infarction middle-aged men. Scand J Clin Lab Invest 65 (2005) 485-490
9. Decsi T., Csábi G., Török K., Erhardt E., Minda H., Burus I., et al. Polyunsaturated fatty acids in plasma lipids of obese children with and without metabolic cardiovascular syndrome. Lipids 35 (2000) 1179-1184
10. Laaksonen D.E., Lakka T.A., Lakka H.M., Nyyssönen K., Rissanen T., Niskanen L.K., et al. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med 19 (2002) 456-464
11. Klein-Platat C., Drai J., Oujaa M., Schlienger J.L., and Simon Ch. Plasma fatty acid composition is associated with the metabolic syndrome and low grade inflammation in overweight adolescent. Am J Clin Nutr 82 (2005) 1178-1184
12. Laakso M. Gene variants, insulin resistance, and dyslipidemia. Curr Opin Lipidol 15 (2004) 115-120
13. Bakillah A., and El Abbouyi A. The role of microsomal triglyceride transfer protein in lipoprotein assembly: an update. Front Biosci 8 (2003) 294-305
14. Berriot-Varoqueaux N., Aggerbeck L.P., Samson-Bouma M.E., and Wetterau J.R. The role of the microsomal triglyceride transfer protein in abetalipoproteinemia. Annu Rev Nutr 20 (2000) 663-697
15. Berthier M.T., Houde A., Paradis A.M., Couture P., Gaudet D., Després J.P., et al. Molecular screening of the microsomal triglyceride transfer protein: association between polymorphisms and both abdominal obesity and plasma apolipoprotein concentrations. J Hum Genet 49 (2004) 684-690
16. Bernard S., Touzet S., Personne I., Lapras V., Bondon P.J., Berthezène F., et al. Association between microsomal triglyceride transfer protein gene polymorphisms and biological features of liver steatosis in patients with type II diabetes. Diabetologia 43 (2000) 995-999
17. Namikawa C., Shu-Ping Z., Vyselaar J.R., Nozaki Y., Nemoto Y., Ono M., et al. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J Hepatol 40 (2004) 853-856
18. Lin M.C., Gordon D., and Wetterau J.R. Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression. J Lipid Res 36 (1995) 1073-1081
19. Gordon D.A., and Jamil H. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Biochim Biophys Acta 1486 (2000) 72-83
20. Chen S.P., Tan K.C., and Lam K.S. Effect of the microsomal triglyceride transfer protein -493 G/T polymorphism and type 2 diabetes mellitus on LDL subfractions. Atherosclerosis 167 (2003) 287-292
21. Ledmyr H., Karpe F., Lundahl B., Mc Kinnon M., Skoglund-Andersson C., and Ehrenborg E. Variants of the microsomal triglyceride transfer protein gene are associated with plasma cholesterol levels and body mass index. J Lipid Res 43 (2002) 51-58
22. Juo S.H., Han Z., Smith J.D., Colangelo L., and Liu K. Common polymorphism in promoter of microsomal triglyceride transfer protein gene influences cholesterol, ApoB, and triglyceride levels in young African American men: results from the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb Vasc Biol 20 (2000) 1316-1322
23. Li R.S., Yin R.X., Lin W.X., and Yang D.Z. Relationship between the polymorphism of microsomal triglyceride transfer protein gene and the level of serum lipids in Guangxi Heiyi Zhuang population. Zhuanghua Yi Xue Za Zhi 85 (2005) 2492-2496
24. Couture P., Otvos J.D., Cupples L.A., Wilson P.W., Schaefer E.J., and Ordovas J.M. Absence of association between genetic variation in the promoter of the microsomal triglyceride transfer protein gene and plasma lipoproteins in the Framingham Offspring Study. Atherosclerosis 148 (2000) 337-343
25. Stan S., Lambert M., Delvin E., Paradis G., O'Loughlin J., Hanley J.A., et al. Intestinal fatty acid binding protein and microsomal triglyceride transfer protein polymorphisms in French-Canadian youth. J Lipid Res 46 (2005) 320-327
26. Kunešová M., Hainer V., Tvrzická E., Phinney S.D., Štich V., Pařízková J., et al. Assessment of dietary and genetic factors influencing serum and adipose fatty acid composition in obese female identical twins. Lipids 37 (2002) 27-32
27. Alberti K.G., Zimmet P., and Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23 (2006) 469-480
28. In: Lochman T., Roche A., and Martorel R. (Eds). Standardization of anthropometric measurements (1989), Human Kinetics Publishers, Champaign (Ill) 39-80
29. Durnin J.V., and Womersley J. Body fat assessed from the total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 71 years. Br J Nutr 32 (1974) 7-97
30. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
31. Ahotupa M., Ruutu M., and Mäntylä E. Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. Clin Biochem 29 (1996) 139-144
32. Tvrzická E., Vecka M., Staňková B., and Žák A. Analysis of fatty acids in plasma lipoproteins by gas chromatography-flame ionisation detection. Quantitative aspects. Anal Chim Acta 465 (2002) 337-350
33. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31 (1990) 545-548
34. Jáchymová M., Horký K., Bultas J., Kožich V., Jindra A., Peleška J., et al. Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem Biophys Res Commun 284 (2001) 426-430
35. Karpe F., Lundahl B., Ehrenborg E., Eriksson P., and Hamsten A. A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels. Arterioscler Thromb Vasc Biol 18 (1998) 756-761
36. Dixon W.J. BMDP Statistical Software Manual Vol. 1-2 (1992), University of California Press, Los Angeles
37. Lundahl B., Hamsten A., and Karpe F. Postprandial plasma ApoB-48 levels are influenced by a polymorphism in the promoter of the microsomal triglyceride transfer protein gene. Arterioscler Thromb Vasc Biol 22 (2002) 289-293
38. Yamada Y., Ando F., and Shimiokata H. Association of microsomal triglyceride transfer protein gene polymorphism with blood pressure in Japanese women. Int J Mol Med 17 (2006) 83-88
39. Lundahl B., Leren T.P., Leiv O., Hamsten A., and Karpe F. A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP-493G/T) influences lipoprotein phenotype in familiar hypercholesterolemia. Arterioscler Thromb Vasc Biol 20 (2000) 1784-1788
40. Lundahl B., Skoglund-Andreson C., Caslake M., Bedford D., Stewart P., Hamsten A., et al. Microsomal transfer protein -493 variant reduces IDL+LDL apoB production and plasma concentration of large LDL particles. Am J Physiol Endocrinol Metab 290 (2006) E739-E745
41. Ledmyr H., McMahon A.D., Ehrenborg E., Nielsen L.B., Neville M., Lithell H., et al. The microsomal triglyceride transfer protein gene -493T variant lowers cholesterol but increases the risk of coronary heart disease. Circulation 109 (2004) 2279-2284
42. Park Y.W., Shankuan Z., Palaniappan L., Heshka S., Carnethon M.R., and Heymsfield S.B. The metabolic syndrome. Prevalence and associated risk factor findings in the US population from the 3rd National Health and Nutritional Examination Survey, 1998 -1994. Arch Intern Med 163 (2003) 427-436
43. Vanhala M.J., Pitkajarvi T.K., Kumpusalo E.A., and Takala J.K. Obesity type and clustering of insulin resistance-associated cardiovascular risk factors in middle-aged men and women. Int J Obes Relat Metab Disord 22 (1998) 369-374
44. Reaven G.M. Banting Lecture 1988. The role of insulin resistance in human disease. Diabetes 37 (1998) 1595-1607
45. St-Pierre J., Lemieux I., Miller-Felix I., Prud'homme D., Bergeron J., Gaudet D., et al. Visceral obesity and hyperinsulinemia modulate the impact of the microsomal triglyceride transfer protein -493G/T polymorphism on plasma lipoprotein level in men. Atherosclerosis 160 (2002) 317-324
46. Fonseca V.A. The metabolic syndrome, hyperlipidemia, and insulin resistance. Clin Cornerstone 7 (2005) 61-72
47. Lewis G.F., Carpentier A., Adeli K., and Giacca A. Disorder of fat storage and mobilization in the pathogenesis of insulin resistance and type I diabetes. Endocr Rev 23 (2002) 201-229
48. McGarry J.D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51 (2002) 7-18
49. Chan D.C., Barrett P.H., and Watts G.F. Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders. Curr Opin Lipidol 17 (2006) 28-36
50. Avramoglu R.K., Basciano H., and Adeli K. Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta 368 (2006) 1-19
51. Warensjö E., Riserus U., and Vessby B. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 48 (2005) 1999-2005
52. Ohara Y., Peterson T.E., and Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91 (1993) 1163-1186
53. Furukawa S., Fujita K., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114 (2004) 1752-1761
54. Ceriello A., and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24 (2004) 816-823
55. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat?. Diabetes 54 (2005) 1-7
56. Fujita K., Nishizawa H., Funahashi T., Shimomura I., and Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 70 (2006) 1437-1442